menu
    • menu
    [{"orgOrder":0,"company":"Pharmactive Biotech Products S.L","sponsor":"Pharmactive Biotech Products S.L","pharmaFlowCategory":"DU","therapeuticArea":"Cardiology\/Vascular Diseases","country":"SPAIN","productType":"Dietary Supplement","year":"2021","type":"Inapplicable","leadProduct":"Abg+ Black Garlin","moa":"Undisclosed","graph1":"Cardiology\/Vascular Diseases","graph2":"Undisclosed","graph3":"Pharmactive Biotech Products S.L","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Cardiovascular Diseases","amount2New":0,"dosageForm":"Tablet","sponsorNew":"Pharmactive Biotech Products S.L \/ Pharmactive Biotech Products S.L","highestDevelopmentStatusID":"1","companyTruncated":"Pharmactive Biotech Products S.L \/ Pharmactive Biotech Products S.L"},{"orgOrder":0,"company":"Pharmactive Biotech Products S.L","sponsor":"Pharmactive Biotech Products S.L","pharmaFlowCategory":"DU","therapeuticArea":"Ophthalmology","country":"SPAIN","productType":"Plant Extract\/Herbal","year":"2022","type":"Inapplicable","leadProduct":"Saffron Extract","moa":"Undisclosed","graph1":"Ophthalmology","graph2":"Undisclosed","graph3":"Pharmactive Biotech Products S.L","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Ophthalmology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Pharmactive Biotech Products S.L \/ Pharmactive Biotech Products S.L","highestDevelopmentStatusID":"1","companyTruncated":"Pharmactive Biotech Products S.L \/ Pharmactive Biotech Products S.L"},{"orgOrder":0,"company":"Pharmactive Biotech Products S.L","sponsor":"Pharmactive Biotech Products S.L","pharmaFlowCategory":"DU","therapeuticArea":"Ophthalmology","country":"SPAIN","productType":"Plant Extract\/Herbal","year":"2024","type":"Inapplicable","leadProduct":"Saffron Extract","moa":"Undisclosed","graph1":"Ophthalmology","graph2":"Undisclosed","graph3":"Pharmactive Biotech Products S.L","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Ophthalmology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Pharmactive Biotech Products S.L \/ Pharmactive Biotech Products S.L","highestDevelopmentStatusID":"1","companyTruncated":"Pharmactive Biotech Products S.L \/ Pharmactive Biotech Products S.L"},{"orgOrder":0,"company":"Pharmactive Biotech Products S.L","sponsor":"Pharmactive Biotech Products S.L","pharmaFlowCategory":"DU","therapeuticArea":"Cardiology\/Vascular Diseases","country":"SPAIN","productType":"Undisclosed","year":"2024","type":"Inapplicable","leadProduct":"Undisclosed","moa":"Undisclosed","graph1":"Cardiology\/Vascular Diseases","graph2":"Undisclosed","graph3":"Pharmactive Biotech Products S.L","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Cardiovascular Diseases","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Pharmactive Biotech Products S.L \/ Pharmactive Biotech Products S.L","highestDevelopmentStatusID":"1","companyTruncated":"Pharmactive Biotech Products S.L \/ Pharmactive Biotech Products S.L"}]

    Find Clinical Drug Pipeline Developments & Deals by Pharmactive Biotech Products S.L

    Menu

    Pharmactive Biotech Products S.L

    EVENTS

    • Webinars & Exhibitions

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass
    Xls
    Filters Filter
    ×
    FILTER:
    filter
    Company Name
      filter

      Year

        filter

        DEALS // DEV.

          filter

          Country

            filter
            Sponsor
              filter

              Therapeutic Area

                filter

                Study Phase

                  filter

                  Deal Type

                    filter

                    Product Type

                      filter

                      Dosage Form

                        filter

                        Lead Product

                          filter

                          Target

                            Loading...
                            refresh Filters
                            refresh Reset Filter
                            refresh Reset Filter
                            price-trend All Developments

                            Therapeutic Area by Lead Product

                            Study Phase by Lead Product

                            Company by Lead Product

                            Top Deals by Deal Size (USD bn)

                            01

                            Pharmactive Biotech Products S.L

                            Spain arrow
                            Organic Process R&D
                            Not Confirmed

                            Pharmactive Biotech Products S.L

                            Spain arrow
                            Organic Process R&D
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : Undisclosed

                            Therapeutic Area : Cardiology/Vascular Diseases

                            Study Phase : Undisclosed

                            Recipient : Universitat de Lleida

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            DEALS_DEV arrow-down

                            ABG+/GarlACE Effects on Cardiovascular Risk Factors in Subjects With Grade I Hypertension

                            Details : This drug candidate is currently being evaluated in clinical studies for the treatment of Hypertension.

                            Product Name : Undisclosed

                            Product Type : Undisclosed

                            Upfront Cash : Inapplicable

                            February 20, 2024

                            Lead Product(s) : Undisclosed

                            Therapeutic Area : Cardiology/Vascular Diseases

                            Highest Development Status : Undisclosed

                            Recipient : Universitat de Lleida

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth

                            02

                            Pharmactive Biotech Products S.L

                            Spain arrow
                            Organic Process R&D
                            Not Confirmed

                            Pharmactive Biotech Products S.L

                            Spain arrow
                            Organic Process R&D
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : Saffron Extract

                            Therapeutic Area : Ophthalmology

                            Study Phase : Undisclosed

                            Recipient : University of Alicante

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            DEALS_DEV arrow-down

                            Effects of AffronEye®/ Crocuvis+® on Dry Eye Syndrome

                            Details : Saffron Extract is a Plant Extract/Herbal drug candidate, which is currently being evaluated in clinical studies for the treatment of Dry Eye Syndromes.

                            Product Name : Undisclosed

                            Product Type : Plant Extract/Herbal

                            Upfront Cash : Inapplicable

                            February 05, 2024

                            Lead Product(s) : Saffron Extract

                            Therapeutic Area : Ophthalmology

                            Highest Development Status : Undisclosed

                            Recipient : University of Alicante

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth

                            03

                            Pharmactive Biotech Products S.L

                            Spain arrow
                            Organic Process R&D
                            Not Confirmed

                            Pharmactive Biotech Products S.L

                            Spain arrow
                            Organic Process R&D
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : Saffron Extract

                            Therapeutic Area : Ophthalmology

                            Study Phase : Undisclosed

                            Recipient : University of Alicante

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            DEALS_DEV arrow-down

                            Effects of CROCUVIS+® on Computer Vision Syndrome, Sleep and Mood Disorders

                            Details : Saffron Extract is a Plant Extract/Herbal drug candidate, which is currently being evaluated in clinical studies for the treatment of Computer Vision Syndrome.

                            Product Name : Undisclosed

                            Product Type : Plant Extract/Herbal

                            Upfront Cash : Inapplicable

                            January 27, 2022

                            Lead Product(s) : Saffron Extract

                            Therapeutic Area : Ophthalmology

                            Highest Development Status : Undisclosed

                            Recipient : University of Alicante

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth

                            04

                            Pharmactive Biotech Products S.L

                            Spain arrow
                            Organic Process R&D
                            Not Confirmed

                            Pharmactive Biotech Products S.L

                            Spain arrow
                            Organic Process R&D
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : Abg+ Black Garlin

                            Therapeutic Area : Cardiology/Vascular Diseases

                            Study Phase : Undisclosed

                            Recipient : Universitat de Lleida

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            DEALS_DEV arrow-down

                            Black Garlic Nutraceuticals and Blood Pressure Control

                            Details : Abg+ Black Garlin is a Dietary Supplement drug candidate, which is currently being evaluated in clinical studies for the treatment of Hypertension.

                            Product Name : Undisclosed

                            Product Type : Dietary Supplement

                            Upfront Cash : Inapplicable

                            June 07, 2021

                            Lead Product(s) : Abg+ Black Garlin

                            Therapeutic Area : Cardiology/Vascular Diseases

                            Highest Development Status : Undisclosed

                            Recipient : Universitat de Lleida

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth